DMSO in Pharmaceutical & Personal-Care Formulations: A Sourcing Guide for B2B Buyers
USP, EP, JP monographs, ICH Q3C residual-solvent class, approved drug examples, and a COA checklist for regulated formulations.
Pharmaceutical-grade dimethyl sulfoxide (DMSO, CAS 67-68-5) is a well-established excipient in approved drug products. It carries an FDA inactive-ingredient listing, official monographs in USP, EP and JP, and an ICH Q3C Class 3 classification (lowest-risk residual-solvent category, with a permitted daily exposure of ≥50 mg/day). It is one of very few aprotic solvents that survives modern pharma scrutiny - the others, DMF / DMAc / NMP, are now Repr. 1B in the EU and increasingly hard to defend in regulatory filings.
That regulatory position has consequences for sourcing. Buying USP-grade DMSO is not the same as buying technical-grade material with a generic spec sheet. The COA, the supplier audit, the packaging, and the residual-solvent panel all change. This article walks through what regulated buyers - pharmaceutical formulators, contract manufacturers, personal-care product owners - actually need to verify on a DMSO procurement, with reference to the official monographs and approved-drug precedents. To request our pharma-grade DMSO documentation, see the DMSO product page.
01. Why Formulators Choose DMSO 💡
DMSO offers pharmaceutical and personal-care formulators four distinctive properties at once - a combination almost no other excipient delivers:
- Universal solubilizing power. DMSO dissolves an unusually wide range of polar and non-polar APIs and excipients. For poorly water-soluble actives (BCS Class II / IV), DMSO often delivers acceptable solubility where water, ethanol, and propylene glycol fail.
- Skin penetration enhancement. DMSO temporarily fluidizes the lipid bilayers of the stratum corneum, delivering APIs into the deeper epidermis at much higher rates than aqueous or alcohol vehicles. This is the basis of DMSO-containing topical analgesics and dermatologic formulations.
- Low toxicity for an aprotic solvent. ICH Q3C Class 3, oral LD50 in rats ~14–28 g/kg, no IARC / NTP carcinogen listing, no EU CLP reproductive-toxicant classification. (For full data see our DMSO toxicity article.)
- Compatibility with sterile filtration. DMSO can be filtered through 0.2 μm polyethersulfone membranes without degradation, which makes it suitable for parenteral and sterile-product workflows.
02. Approved Drug Products Using DMSO 💊
Several FDA-approved drug products use DMSO as a critical functional excipient. These are not theoretical - they are commercially marketed pharmaceuticals whose precedent value supports new submissions using DMSO:
| Product | DMSO Role | Approval / Indication |
|---|---|---|
| Pennsaid (1.5 % & 2 % topical diclofenac sodium) | 45.5 % w/w DMSO as penetration-enhancing carrier | FDA-approved for osteoarthritis pain (knee) |
| RIMSO-50 (50 % DMSO solution) | DMSO is the active substance, intravesical instillation | FDA-approved for interstitial cystitis |
| Onyx Liquid Embolic | DMSO as solvent for ethylene-vinyl-alcohol copolymer; precipitates in blood vessel to occlude | FDA-approved Class III medical device for cerebral AVM embolization |
| Idamycin (idarubicin) reconstitution | DMSO as solvent in some idarubicin parenteral formulations historically | Acute myeloid leukemia (chemotherapy) |
| Veterinary topical analgesics | DMSO as carrier (veterinary equivalents of Pennsaid for equine and canine use) | FDA-approved veterinary applications for equine musculoskeletal injuries |
The Pennsaid precedent is particularly useful for new topical-product submissions: it establishes that 45.5 % DMSO as a carrier is acceptable in chronic-use topical drugs, with safety data supporting daily application over months.
03. ICH Q3C Class 3 Status 🌐
The ICH Q3C(R8) "Impurities: Guideline for Residual Solvents" classifies all solvents used in pharmaceutical manufacturing into three classes based on toxicity. DMSO sits in Class 3 - Solvents with low toxic potential, the lowest-risk category.
| ICH Q3C Class | Description | Examples |
|---|---|---|
| Class 1 - Avoid | Known carcinogens, environmental hazards | Benzene, carbon tetrachloride, 1,2-dichloroethane, 1,1,1-trichloroethane |
| Class 2 - Limit | Animal carcinogens, irreversible / significant toxicity; PDE-based limits required | DMF, NMP, DMAc, methanol, acetonitrile, dichloromethane, hexane, pyridine |
| Class 3 - Low Risk | Low toxic potential to humans; PDE ≥ 50 mg/day; no health-based exposure limit needed | DMSO, ethanol, isopropanol, ethyl acetate, acetone, butanol, formic acid |
What Class 3 means in regulatory practice. Residual DMSO in a final drug product up to 0.5 % w/w (5,000 ppm) is generally acceptable without further toxicological justification. Higher residuals are also acceptable when a full toxicology rationale supports them, and DMSO at much higher concentrations is used in approved formulations like Pennsaid (45.5 % DMSO) and RIMSO-50 (50 % DMSO).
04. USP / EP / JP Monograph Comparison 📑
Three of the major pharmacopoeias publish official monographs for DMSO. The chemistry is identical; the analytical specifications differ slightly. A pharma-grade DMSO supplier should be able to deliver material conforming to all three on the same COA.
| Spec Item | USP | EP (Ph. Eur.) | JP |
|---|---|---|---|
| Assay (GC purity) | ≥ 99.9 % | ≥ 99.9 % | ≥ 99.0 % |
| Refractive index nD20 | 1.4783 – 1.4787 | 1.478 – 1.479 | 1.478 – 1.479 |
| Density (20 °C) | 1.100 – 1.101 g/cm³ | 1.100 – 1.104 g/cm³ | 1.100 – 1.104 g/cm³ |
| Water (Karl Fischer) | ≤ 0.1 % | ≤ 0.2 % | ≤ 0.2 % |
| Color (APHA) | ≤ 20 | Specified by reference | Specified by reference |
| UV absorbance | Limits at 275 nm and elsewhere | Limits at 275, 285, 295 nm | Limits at 275, 285, 295 nm |
| Heavy metals | ≤ 5 ppm | ≤ 5 ppm | ≤ 10 ppm |
| Acidity / alkalinity | Specified titration | Specified titration | Specified titration |
A pharma-grade DMSO COA should explicitly state which monograph(s) the material conforms to. Multi-compendia conformance ("Meets USP, EP, JP") is the gold standard, since it preserves regulatory flexibility for product registration in any region.
05. DMSO in Topical, Gel, Cream & Ointment Formulations 🧪
In topical pharmaceuticals, DMSO appears at concentrations from 5 % up to 90 %, depending on formulation goal:
| DMSO Range | Formulation Role | Typical Application |
|---|---|---|
| 5 – 15 % | Mild penetration enhancer / co-solvent | Cosmetic actives, mild topicals |
| 15 – 50 % | Active penetration enhancement | Topical analgesics (Pennsaid range), dermatologic creams |
| 50 – 90 % | Primary vehicle / solvent for poorly soluble APIs | Specialty steroid lotions, gels, embolic carriers |
| ≥ 95 % | Bulk active substance | RIMSO-50 (50 %), neat-DMSO veterinary use |
Mechanism of penetration enhancement. DMSO temporarily disrupts the lipid lamellae of the stratum corneum, reduces the integrity of corneocyte protein matrices, and increases the partition coefficient of dissolved actives into the skin. The effect is concentration-dependent - at 60 – 90 % DMSO, penetration enhancement of dissolved actives can be 20- to 100-fold over aqueous vehicles. (See our companion article on DMSO as a skin penetration enhancer for the molecular biology.)
06. DMSO in Personal-Care & Cosmetics 💆
Outside regulated drug products, DMSO appears in personal-care formulations primarily as a low-concentration co-solvent and penetration enhancer. The cosmetic-grade material is essentially identical to USP / EP DMSO in chemistry; the difference is in the regulatory documentation and labeling rather than the molecule itself.
Common cosmetic applications:
- Active penetration enhancement for niacinamide, salicylic acid, retinoids, and plant-extract actives
- Solvent for fragrances and color additives in clear-formulation products
- Stability aid in transdermal-delivery cosmeceuticals
- Specialty hair-care applications (scalp serums, hair-growth formulations)
07. Packaging & Container Compatibility 📦
One of the under-appreciated formulation challenges with DMSO is polymer compatibility. DMSO swells, dissolves, or extracts plasticizers from many common pharmaceutical container materials. The official guidance from the published pharma technology literature is unambiguous: only HDPE (high-density polyethylene), HDPP (high-density polypropylene), and PTFE (polytetrafluoroethylene) are suitable for high-DMSO-content products.
| Material | DMSO Compatibility |
|---|---|
| HDPE (high-density polyethylene) | ✅ Excellent - primary container material for DMSO products |
| HDPP (high-density polypropylene) | ✅ Excellent - closures, caps, secondary containers |
| PTFE (Teflon) | ✅ Excellent - gaskets, valve seats, tubing in critical service |
| Type I borosilicate glass | ✅ Excellent - laboratory and small-batch use |
| 316L stainless steel | ✅ Excellent - bulk manufacturing tanks, ISO containers |
| LDPE (low-density polyethylene) | ⚠️ Acceptable for short-term use only - DMSO swells over weeks |
| PVC, polycarbonate, polystyrene | ❌ Not compatible - DMSO dissolves or severely swells these polymers |
| Most rubbers (natural, EPDM, nitrile) | ❌ Plasticizer leaching, DMSO swelling - avoid for DMSO ≥ 30 % |
| Mild / carbon steel | ❌ Slow corrosion, iron pickup → product yellowing |
For pharma and personal-care formulations using ≥ 30 % DMSO, full extractables / leachables (E&L) testing on the chosen primary packaging is required, per ICH Q3D and USP <1663> / <1664>. The pharma-grade DMSO supplier should ship in HDPE drums or HDPE-lined IBCs with PTFE or HDPP closures.
08. Sourcing Pharma-Grade DMSO from China 🌏
China has become a major pharma-grade DMSO production hub over the past decade. Several Chinese manufacturers - including Sinolook's manufacturing partners - produce material that conforms to USP / EP / JP with full ICH Q3C residual-solvent and heavy-metal testing. For Western and emerging-market buyers, the cost advantage of Chinese pharma DMSO is meaningful; the regulatory and audit work is comparable to sourcing from any other country.
Items to confirm before approving a China-sourced pharma DMSO supplier:
- Manufacturer (not trader) status. Many Chinese DMSO listings are from trading companies, not the manufacturing site. For pharma use, direct manufacturer relationships allow audits and traceability.
- cGMP statement for the manufacturing facility - ideally with a declaration of compliance with ICH Q7 for APIs / excipients.
- Chinese pharmacopoeia (ChP) monograph compliance in addition to USP / EP / JP for full international flexibility.
- FDA DMF (Drug Master File) reference if available - not strictly required for excipients but valuable.
- Audit report - third-party (e.g., Rephine, EXCiPACT) audit reports for the manufacturing site.
- Trial-quantity supply for formulation validation before bulk commitment.
- Stability and retest documentation - minimum 24-month shelf-life data on validated packaging.
09. The Pharma-Grade DMSO COA Checklist ✅
Every shipment of pharma-grade DMSO should arrive with a batch-specific COA listing all of the following. If any item is missing or "not tested," the material is not pharma-grade regardless of what the spec sheet calls it:
- ✅ Identification - IR spectrum or alternate identification per pharmacopoeial method
- ✅ Assay (GC purity) - ≥ 99.9 % w/w (USP / EP) or ≥ 99.0 % (JP)
- ✅ Refractive index nD20 - within compendial range
- ✅ Density at 20 °C - 1.100 – 1.101 g/cm³
- ✅ Water (Karl Fischer) - ≤ 0.1 % (USP), ≤ 0.2 % (EP / JP)
- ✅ Color (APHA) - ≤ 20
- ✅ UV absorbance at 275 nm and other compendial wavelengths
- ✅ Heavy metals - ≤ 5 ppm; ICH Q3D elemental impurities panel for parenteral use
- ✅ Acidity / alkalinity - within compendial titration range
- ✅ Residual solvents (ICH Q3C) - full panel by GC headspace
- ✅ Microbial count and endotoxin - for sterile-filtered grade, when applicable
- ✅ Batch number, manufacturing date, retest date
- ✅ Statement of compendial conformance ("Meets USP, EP, JP" ideal)
- ✅ Authorized signature from the manufacturer's QA / QC department
Frequently Asked Questions
Pharmaceutical-grade DMSO is dimethyl sulfoxide manufactured and tested to conform to one or more pharmacopoeial monographs - USP (United States), EP (European), JP (Japanese), or ChP (Chinese). Each monograph specifies analytical methods and acceptance criteria for assay, refractive index, density, water, color, UV absorbance, heavy metals, acidity, and residual solvents. Pharma-grade DMSO arrives with a batch-specific COA documenting compliance.
Yes - DMSO has FDA approval in several specific products. RIMSO-50 (50 % DMSO) is approved for treating interstitial cystitis. Pennsaid (1.5 % and 2 % topical diclofenac in 45.5 % DMSO) is approved for osteoarthritis pain. The Onyx Liquid Embolic system using DMSO as solvent is FDA-approved as a Class III medical device. DMSO also has approved veterinary indications.
Class 3 - the lowest-risk category. Class 3 solvents are considered to have low toxic potential to humans and have a permitted daily exposure (PDE) of ≥ 50 mg per day with no health-based exposure limit needed. This contrasts with DMF, DMAc, and NMP, which are all Class 2 (limited).
Cosmetic-grade DMSO at typical use concentrations in personal-care products (5–15 %) has a strong safety record. Higher concentrations require regulatory review. Pharma-grade DMSO is widely used in approved topical pharmaceuticals at concentrations up to 45.5 % (Pennsaid) for chronic daily use. The material grade matters: technical-grade DMSO is not appropriate for any skin-contact product because of potential trace impurities.
HDPE, HDPP, or PTFE for primary packaging of DMSO-containing formulations at ≥ 30 % DMSO. Type I borosilicate glass is also acceptable for small batches. PVC, polycarbonate, polystyrene, and most rubbers are not compatible - DMSO dissolves or swells them. Always perform extractables / leachables testing on your specific final-container choice per ICH Q3D and USP <1663>.
Sinolook Chemical Co., Ltd. supplies pharma-grade DMSO conforming to USP, EP, and JP monographs, with batch-specific COA, full ICH Q3C residual-solvent testing, and HDPE drum / IBC packaging. Request a sample for formulation qualification through the contact details below or visit our DMSO product page.
📚 Authoritative References
- ICH - Q3C(R8) Impurities: Guideline for Residual Solvents
- USP - USP-NF Monographs & General Chapter <467> Residual Solvents
- European Pharmacopoeia - EDQM Pharmacopoeial Database
- Pharmaceutical Technology - DMSO USP, PhEur in Approved Pharmaceutical Products and Medical Devices
- U.S. FDA - Inactive Ingredient Database (DMSO entries)
- EU - Regulation (EC) No 1223/2009 on Cosmetic Products
🔗 Continue Reading - DMSO Knowledge Hub
Pharmaceutical & Cosmetic-Grade DMSO from China - USP / EP / JP
Sinolook Chemical Co., Ltd. supplies pharma-grade dimethyl sulfoxide (CAS 67-68-5) conforming to USP / EP / JP monographs, with full ICH Q3C residual-solvent testing, batch-specific COA, and HDPE drum / IBC packaging. Cosmetic-grade and personal-care-grade DMSO also available, with regulatory documentation for 50+ countries.
